Navigation Links
EDDA Technology Introduces Universal Enterprise Solution - Enabling 2D/3D/4D Advanced Clinical Applications on Existing PACS Workstations

PRINCETON JUNCTION, N.J., Nov. 19 /PRNewswire/ -- Highlighted by the introduction of the IQQA(R) Enterprise Engine technology, EDDA is now reaching the broad radiology imaging market with its universal enterprise solution, which enables fast delivery and easy access of 2D/3D/4D advanced clinical applications on existing PACS workstations in virtually any hospital PACS environment without code-level integration. Available on the IQQA(R) Enterprise Engine are IQQA(R)-Chest for digital X-Ray lung nodule CAD, and IQQA(R)-Liver for contrast MDCT. The IQQA(R) Enterprise Engine is also capable of accommodating third party imaging applications.

IQQA(R)-Chest is the only FDA cleared system to offer real-time interactive diagnostic analysis of digital chest X-rays using a comprehensive set of tools to support physicians in their identification, confirmation and quantification of lung nodules. By offering a solution powered by intelligent tools with real-time interaction, the system seamlessly integrates advanced diagnostic analysis technologies into physicians' softcopy reading process for improved workflow and clinical decision making. Published clinical studies have suggested that IQQA(R)-Chest may help physicians' identification of small lesions and reduce inter-observer variation. With the number of chest X-rays that are read on a daily basis worldwide, the immediacy provided by IQQA(R)-Chest Enterprise allows for expanded use of chest CAD tools on a routine basis, with the prospect of enhancing diagnostic quality on a broad scale.

IQQA(R)-Liver Enterprise addresses the clinical challenge faced by physicians in efficiently dealing with tremendous data volume from contrast MDCT images of the liver. Combining advanced image analysis algorithms and powerful visualization tools, the software supports physicians to quickly and effectively distill critical diagnostic information from data volume of extraordinary size. It performs automatic anatomy-based phase registration to allow simultaneous visualization and easy cross-referencing of lesion location and characteristics across different phases. IQQA(R)-Liver Enterprise further provides 3D segmentation and measurement tools for visualization and analysis of liver, liver lesions, and vascular structures. This volumetric analysis not only provides physicians with a powerful visualization aid, but also offers quantification tools to support their clinical decision making and patient care management.

The enabling IQQA(R) Enterprise Engine (IQQA(R)-EE) technology is a direct response to the critical challenge that physicians and hospital IT now face in integrating more and more advanced clinical applications into existing PACS workflow. Access to such applications via dedicated stand-alone workstations is no longer accepted as an option in an already stressed workflow. Although static image results could often be sent from these stand-alone workstations back to a primary PACS workstation for review, it is still not possible to enjoy access to the full interactive functionality of these advanced applications at the PACS viewing station.

The IQQA(R) Enterprise Engine aims to redefine how advanced clinical application can be accessed by physicians and managed by hospital IT. Physicians can now enjoy immediate access to the full real-time 2D/3D/4D functionality of advanced clinical applications at existing PACS viewing stations. In addition, since the solution does not require code level integration with existing hospital PACS environment, application installation is completed quickly by simply setting up network communication. Possible additional maintenance resources of having to keep up with periodic PACS software upgrade are also saved.

"EDDA is committed to innovation in delivering diagnostic aid solutions. Not only do we develop advanced clinical applications to help improve the early detection, early diagnosis and precise treatment of lethal diseases, but also we see the tremendous importance of the innovative delivery mechanism to enable broad access to such applications," says Dr. Jian-Zhong Qian, President and CEO of EDDA Technology. "From the success of development of IQQA(R)-Chest Enterprise to IQQA(R)-Liver Enterprise, the IQQA(R) Enterprise Engine demonstrates a new economic way to integrate 2D/3D/4D applications with virtually any existing hospital PACS systems without code level integration. Considering the trend of emerging advanced clinical applications for diagnostic decision aid, the impact of such accessibility enabling technology to deliver diagnostic aid on a broad scale will be significant."

The IQQA(R) Enterprise Engine has been successfully demonstrated to run in numerous PACS environments including AGFA, Dynamic Imaging, GE, Kodak, McKesson, Philips, Siemens, etc.

EDDA Technology will be exhibiting the IQQA(R) Family of Clinical Applications and Platforms in Booth #6534 in the North Hall of McCormick Place at the 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), November 25 - 30, 2007.

About EDDA Technology

EDDA Technology, Inc. is an innovative clinical computer solution provider in diagnostic imaging and analysis. EDDA offers a series of new generation software products to enable early detection of diseases, and enhance efficiency and precision in diagnosis and treatment. EDDA's goal is to deliver, with broad accessibility, advanced information analysis technologies that improve clinical workflow and accuracy. A privately held Delaware corporation, EDDA is headquartered in Princeton Junction, New Jersey, and has a subsidiary in Shanghai, China. IQQA is a registered trademark of EDDA Technology. For further information, please log on to, or call 609-936-8282.

SOURCE EDDA Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. Novel Technology Breaks Through Cancer Pain
3. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
4. Advanced Cell Technology Announces Proposed Financing
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
10. China Technology Announces New Chief Financial Officer
11. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
Post Your Comments:
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/9/2016)... 2016 Paris Police Prefecture ... security solution to ensure the safety of people and operations ... the major tournament Teleste, an international technology group ... announced today that its video security solution will be utilised ... up public safety across the country. The system roll-out is ...
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
Breaking Biology News(10 mins):